Medicine
Desvenlafaxine 100 mg extended-release tablet
Desvenlafaxine 100 mg extended-release tablet is a generic prescription medicine for oral use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Desvenlafaxine
- Brand
- Sold under the generic name
- Strength
- 100 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets, 100 tablets and 61 more
- Manufacturers
- Alembic PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaLupinIndiaBryant Ranch PrepackBreckenridge PharmaceuticalAdvagen PharmaHikma PharmaceuticalsSlate Run PharmaceuticalsActavis Pharma15 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX23 Desvenlafaxine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 March 2013
- Identifiers
- RxCUI 1874553, 1607617, 1874559 +2DailyMed set ID 325be002-4db2-40e9-e063-6394a90ae94e, 44f4b928-d5b8-44e7-bfa6-81fb0dc1a718, 91cf39c9-4d26-480a-a3a3-a3d8d4c4d222 +17NDC 67046-1545, 70436-013, 63304-192 +17Application ANDA204003, ANDA210014, NDA204150 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 15 labelers. The register lists 64 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, extended release in 1 bottle | 46708-153-30 | Alembic PharmaceuticalsIndia | 5 March 2013 |
| 90 tablet, extended release in 1 bottle | 46708-153-90 | Alembic PharmaceuticalsIndia | 5 March 2013 |
| 100 tablet, extended release in 1 carton | 46708-541-10 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 14 tablet, extended release in 1 bottle | 46708-541-17 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 30 tablet, extended release in 1 bottle | 46708-541-30 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 100 tablet, extended release in 1 bottle | 46708-541-31 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 80 tablet, extended release in 1 carton | 46708-541-80 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 90 tablet, extended release in 1 bottle | 46708-541-90 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 1000 tablet, extended release in 1 bottle | 46708-541-91 | Alembic PharmaceuticalsIndia | 1 March 2017 |
| 30 tablet, film coated, extended release in 1 bottle | 68180-593-06 | LupinIndia | 1 March 2017 |
| 30 tablet, extended release in 1 bottle | 33342-389-07 | Macleods PharmaceuticalsIndia | 16 June 2018 |
| 90 tablet, extended release in 1 bottle | 33342-389-10 | Macleods PharmaceuticalsIndia | 16 June 2018 |
| 10 blister pack in 1 carton / 10 tablet, extended release in 1 blister pack | 33342-389-12 | Macleods PharmaceuticalsIndia | 16 June 2018 |
| 30 tablet, extended release in 1 bottle | 63304-192-30 | Sun Pharmaceutical IndustriesIndia | 5 March 2013 |
| 90 tablet, extended release in 1 bottle | 63304-192-90 | Sun Pharmaceutical IndustriesIndia | 5 March 2013 |
| 30 tablet, extended release in 1 bottle | 0591-3660-30 | Actavis Pharma | 1 March 2017 |
| 1000 tablet, extended release in 1 package | 72888-144-00 | Advagen Pharma | 31 January 2022 |
| 500 tablet, extended release in 1 package | 72888-144-05 | Advagen Pharma | 31 January 2022 |
| 30 tablet, extended release in 1 package | 72888-144-30 | Advagen Pharma | 31 January 2022 |
| 90 tablet, extended release in 1 package | 72888-144-90 | Advagen Pharma | 31 January 2022 |
| 100 tablet, extended release in 1 bottle | 51991-312-01 | Breckenridge Pharmaceutical | 1 March 2017 |
| 1000 tablet, extended release in 1 bottle | 51991-312-10 | Breckenridge Pharmaceutical | 1 March 2017 |
| 100 tablet, extended release in 1 carton | 51991-312-11 | Breckenridge Pharmaceutical | 1 March 2017 |
| 14 tablet, extended release in 1 bottle | 51991-312-14 | Breckenridge Pharmaceutical | 1 March 2017 |
| 30 tablet, extended release in 1 bottle | 51991-312-33 | Breckenridge Pharmaceutical | 1 March 2017 |
| 80 tablet, extended release in 1 carton | 51991-312-80 | Breckenridge Pharmaceutical | 1 March 2017 |
| 90 tablet, extended release in 1 bottle | 51991-312-90 | Breckenridge Pharmaceutical | 1 March 2017 |
| 30 tablet, film coated, extended release in 1 bottle | 0054-0401-13 | Hikma Pharmaceuticals | 1 March 2017 |
| 90 tablet, film coated, extended release in 1 bottle | 0054-0401-22 | Hikma Pharmaceuticals | 1 March 2017 |
| 30 tablet, extended release in 1 bottle, plastic | 70436-013-04 | Slate Run Pharmaceuticals | 1 August 2020 |
| 90 tablet, extended release in 1 bottle, plastic | 70436-013-06 | Slate Run Pharmaceuticals | 1 August 2020 |
| 30 tablet, extended release in 1 bottle | 63629-7559-1 | Bryant Ranch Prepack | 19 March 2018 |
| 28 tablet, extended release in 1 bottle | 63629-7559-2 | Bryant Ranch Prepack | 29 October 2024 |
| 90 tablet, extended release in 1 bottle | 63629-7559-3 | Bryant Ranch Prepack | 25 August 2021 |
| 60 tablet, extended release in 1 bottle | 63629-7559-4 | Bryant Ranch Prepack | 29 October 2024 |
| 30 tablet, film coated, extended release in 1 bottle | 71335-1331-1 | Bryant Ranch Prepack | 3 September 2019 |
| 28 tablet, film coated, extended release in 1 bottle | 71335-1331-2 | Bryant Ranch Prepack | 20 May 2024 |
| 90 tablet, film coated, extended release in 1 bottle | 71335-1331-3 | Bryant Ranch Prepack | 20 May 2024 |
| 60 tablet, film coated, extended release in 1 bottle | 71335-1331-4 | Bryant Ranch Prepack | 20 May 2024 |
| 30 tablet, extended release in 1 bottle, plastic | 71335-1815-1 | Bryant Ranch Prepack | 17 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Desvenlafaxine 100 mg extended-release tablet.
Other strengths and forms of Desvenlafaxine
Clinical summary
Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of adults with major depressive disorder (MDD). It is available as extended-release tablets for oral use. MedsAcross supplies Desvenlafaxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DesvenlafaxineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Pristiq Extended-Release prescribing information (Wyeth Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Desvenlafaxine 100 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.